Compare NWGL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWGL | MBOT |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.1M | 73.2M |
| IPO Year | 2022 | 2000 |
| Metric | NWGL | MBOT |
|---|---|---|
| Price | $0.06 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 26.8M | 822.3K |
| Earning Date | 04-27-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.93 |
| 52 Week High | $1.98 | $2.86 |
| Indicator | NWGL | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 25.06 | 48.20 |
| Support Level | N/A | N/A |
| Resistance Level | $0.34 | $2.71 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 0.35 | 60.00 |
CL Workshop Group Ltd, formerly Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.